Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals

CNBC•Mon, Sep 21, 2026, 04:20 AM•2 min read

Chinese biopharma stocks rose on Monday after a report that the U. S. may continue to allow most drug licensing deals with Chinese firms.

Source: [CNBC](https://www.cnbc.com/2026/09/21/chinese-biopharma-stocks-jump-as-us-plans-to-continue-drug-licensing-deals-.html)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at CNBC ↗

#finance #chinese #biopharma #stocks #drug #deals #jump #weighs #keeping

More Headlines

FinanceInvesting.com• 6m ago

Enhertu receives EU committee backing for early breast cancer

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 8m ago

US spirits maker Sazerac launches takeover bid for Germany’s Berentzen

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 8m ago

AI Strategies diverge by 9 points as tech rallies and financials slide

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 9m ago

ZAI shares slide amid row over user data uploads

Developing story — details emerging. Check the source link for the latest updates.

FinanceCNBC• 9m ago

Oil falls as crude flows remain 'surprisingly strong'

Oil fell Monday, as traders keep watch for a recovery in shipments from Saudi Arabia, even as Mideast tensions continue to escalate.

FinanceBloomberg Markets• 16m ago

Black Sea Impasse Adds to Global Economic Damage

The impasse in the Black Sea following a summer escalation in Russia’s war with Ukraine is compounding the economic damage from the conflict in the Middle East by threatening to drive inflation even higher. Connecting Europe and Asia, the Black Sea is a critical conduit for global crop shipments...